Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Ratios

enVVeno Medical (NVNO) Beginning Cash Balance (2017 - 2018)

enVVeno Medical has reported Beginning Cash Balance over the past 2 years, most recently at -$9136.0 for Q2 2018.

For Q2 2018, Beginning Cash Balance changed N/A year-over-year to -$9136.0; the TTM value through Dec 2018 reached $120864.0, changed N/A, while the annual FY2018 figure was $120864.0, 30.83% down from the prior year.
Beginning Cash Balance for Q2 2018 was -$9136.0 at enVVeno Medical, down from $130000.0 in the prior quarter.
Over five years, Beginning Cash Balance peaked at $130000.0 in Q1 2018 and troughed at -$9136.0 in Q2 2018.